← Browse by Condition
Medical Condition
multiple myeloma progression
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 1, Phase 2
NCT07075185 Phase 1
Recruiting
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
Enrollment
40 pts
Location
Australia
Sponsor
Kelonia Therapeutics, Inc.
NCT07032129 Phase 1, Phase 2
Recruiting
Sequential CAR-T Cells Targeting BCMA/GPRC5D in Patients With Relapsed/ Refractory Multiple Myeloma
Enrollment
60 pts
Location
China
Sponsor
Essen Biotech